Share Name Share Symbol Market Type Share ISIN Share Description
Nahl Group LSE:NAH London Ordinary Share GB00BM7S2W63 ORD GBP0.0025
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -2.50p -1.78% 138.00p 138.00p 144.75p 147.00p 138.00p 147.00p 47,730.00 16:35:11
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 50.7 14.0 25.6 5.4 62.58

Nahl Group (NAH) Latest News (2)

More Nahl Group News
Nahl Group Takeover Rumours

Nahl Group (NAH) Share Charts

1 Year Nahl Group Chart

1 Year Nahl Group Chart

1 Month Nahl Group Chart

1 Month Nahl Group Chart

Intraday Nahl Group Chart

Intraday Nahl Group Chart

Nahl Group (NAH) Discussions and Chat

Nahl Group Forums and Chat

Date Time Title Posts
06/12/201612:04NAHL GROUP PLC ORD GBP0.0025518.00
23/7/201515:03NAHL Group plc5.00

Add a New Thread

Nahl Group (NAH) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
16:58:33138.004055.20O
16:35:11138.004055.20UT
16:34:25141.109941,402.53O
16:27:00141.382,5003,534.38O
16:25:09141.387,50010,603.13O
View all Nahl Group trades in real-time

Nahl Group (NAH) Top Chat Posts

DateSubject
06/12/2016
08:20
Nahl Group Daily Update: Nahl Group is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker NAH. The last closing price for Nahl Group was 140.50p.
Nahl Group has a 4 week average price of 201.83p and a 12 week average price of 235.23p.
The 1 year high share price is 295p while the 1 year low share price is currently 138p.
There are currently 45,349,629 shares in issue and the average daily traded volume is 165,649 shares. The market capitalisation of Nahl Group is £62,582,488.02.
02/12/2016
08:56
hybrasil: I'm not gloating. It's a business I know very well. It's share price is vastly overrated at the current. £1.40. It has negative assets. It's a people business. It's barge pole status.
24/3/2016
15:16
jong: As summarised in a recent share trading recommendation by Redmayne Bentley - with a historic P-E ratio of 6.8; net debt a little over £8m and a dividend yield of 9.6%, the recent negative share price action seems somewhat overdone having more than halved from over £4 before the Autumn 2015 announcement.
24/3/2016
09:14
wilk1: Eezy, earnings are growing year on year, can you not read. Albeit, not as quickly as originally anticipated. The share price has halved on growing earnings. The market will tell us what's right and the current share price action wAs chart driven to go back to the last low and let all the city boys in cheap. Now they've loaded up we are going back up quickly. Now do us all a favour here if your not invested and have an early Easter.
22/3/2016
08:18
eezymunny: Still no detail given on how profitable the small Personal Injury biz has been. Given that this might get smashed to pieces in 2017 I find that utterly disgraceful. It does make you wonder if 2017 profits will absolutely collapse along with the share price.
15/3/2016
15:46
ali47fish: does any one when the next update is- last year results were annouced 24th march- given the backdrop and the weak share price has anybody got an idea of what is awaiting us?
10/3/2016
13:12
corrientes: Given that we are now less than two weeks away from results,seems to me anyway,that lack of interest is indicating a damp squib to come, with little or no share price movement. What do you think wilk1 ?
06/3/2016
10:27
wilk1: The market is implying here that earnings are going to fall 40% this year from £15.5m to £9m which would make a pe of ratio of 10 at present share price. With the recent earnings enhancing acquisitions, I for one do not see this happening. I think the market was looking for the long term support at £2. I'll be buying a few more in the morning for sure.
04/3/2016
11:19
imranawan: Good luck Wilk1. I don't have a position myself but had NAH on the w/list. A note of caution Wilk1 - assuming the share price recovers I would strongly recommend reducing the size of your position to reduce risk. You might be a believer but having 66% of your p/folio in one stock is not a wise decision. You need diversification - for exactly times like this. I hold around 30 stocks - which is too many, but a comfortable number for me would be 20. If you do want to run a concentrated p/folio I would recommend a p/folio of 10 stocks to reduce risk.
20/1/2016
17:01
wilk1: After what we've heard today the share price needs to rise a £1 to put the dividend of circa 20p in context. I know there's the uncertainty regarding whiplash but it's only a small part of the turnover. The recent acquisition looked cheap on paper too. Something's got to give here, either the dividend gets cut which is unlikely or the share price has to play catch up. This is better value than FRP IMO. I hold both.
30/5/2015
09:40
oniabsta: This fast-growing "underdog" still yields 6% By Harriet Mann | Fri, 29th May 2015 - 16:51 Share this This fast-growing "underdog" still yields 6% Personal injury marketing firm National Accident Helpline (NAH) has just celebrated its first year on AIM. And it's been quite a ride. The share price is up 50%, boosted by the acquisition of consumer legal marketing group Fitzalan, a cracking set of full-year results and expectations of sustainable double-digit profit growth. There's a knockout dividend yield, too. Acting as the middle-man between personal injury claimants and a panel of 50 lawyers, enquiries from members of the public are the backbone to NAHL's success. Staff at the firm's call centre in Kettering dealt with 248,000 consumer contacts in 2014. Those were then whittled down to 83,000 enquiries suitable to pass onto its lawyers, up 15%. Of these, the company dealt with about 48,000 running cases. And that stringent screening process is paying off, increasing the conversion rate of clean leads to enquiries to 75% last year, well above management's target of 70%. Of the 1 million personal injury claims made in the UK each year, road traffic accidents (RTA) make up the bulk. But expansion in the once quieter areas of non-RTA and medical negligence is gathering pace, with market growth between 2011 and 2014 of 7% and 12%, respectively. NAHL's business model puts more emphasis on these typically higher-value claims, accounting for around three-quarters of enquiries. But with only a 4% share of the £3 billion personal injury market, NAHL has plenty of room to grow. We expect the share price to settle nearer 350p over the course of 2015" Ben Thefaut, Arden Partners Changes to the law in 2013 prohibited marketing companies from being paid by law firms for referrals. This has wiped out some of the market and forced NAHL to adapt - the panel law firms (PLFs) now pays a chunk of NAHL's outgoings, as well as an additional margin cost, accounting for 88% of revenue. Each member pays the billed amount within the month, making the group incredibly cash generative. Over 97% of operating profit was converted into cash last year. This gives management the freedom to reward investors with generous dividends. Currently offering 6% dividend yield, management has promised to pay out two-thirds of retained earnings to shareholders. NAHL worked hard last year on new After the Event (ATE) insurance to fit in with new Legal Aid, Sentencing and Punishment of Offenders Act 2012 (LASPO) regulation. A medical negligence ATE was introduced in November and a new personal injury product will be launched next month. Along with new enhanced screening products and growth of rehab services, NAHL is focused on developing its product and brand. After denouncing cold calling, management rely heavily on NAHL's brand image - the increasingly familiar Underdog character, created in 2010 for television and online marketing. The group has spent £23 million on day-time adverts and internet advertising last year, with 86% of claimants going online. And investment is paying off with a strengthened internet presence and 20 years of experience, which puts it ahead of smaller, lesser-known firms like InjuryLawyers4U, solicitors Irwin Mitchell and First4lawyers. We believe the growth prospects remain very encouraging, both organically through increasing market share in the higher value areas of medical negligence and non-RTA and releasing the growth constraints of Fitzalan, as well as inorganically by acquiring in related areas" Investec Securities Crucially, NAHL's balance sheet is strong enough to bankroll further acquisitions, too, supported by forecast year-end net cash of £1.4 million. The purchase of Fitzalan Partners underpins the City’s double-digit earnings forecasts and broadens NAHL's exposure. This year has gone well, so far, and Arden Partners analyst Ben Thefaut has pencilled in sales growth of 12% to £49.2 million, driving adjusted pre-tax profit up by 14% to almost £13.9 million. Earnings growth of 29% last year is still a considerable 14.4% in 2015, according to Thefaut, then 10% in 2016. On these forecasts, NAHL trades on 11.2 times forward earnings, dropping to 10.1 times. That's undemanding, and there's a prospective yield of almost 6%
Nahl Group share price data is direct from the London Stock Exchange
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V: D:20161206 17:57:42